NVIDIA & Reliance Industries To Create AI Infrastructure – Mightier Than The Fastest Supercomputer In India

Semiconductor company NVIDIA Corp (NASDAQ: NVDA) collaborated with Reliance Industries 

Semiconductor company NVIDIA Corp (NASDAQ:NVDA) collaborated with Reliance Industries to advance AI in India.

As per the deal, the companies will create a foundation large language model trained on diverse languages and tailored for generative AI applications in the country.

With the deal, Reliance Jio Infocomm and Reliance Industries’ telecom are foraying into the AI world.

Akash Ambani, chairman of Reliance Jio Infocomm, said, “Together, we will develop a state-of-the-art AI cloud infrastructure that is secure, sustainable and deeply relevant across India, accelerating the nation’s journey towards becoming an AI powerhouse.”

RelatedMukesh Ambani Takes On Sam Altman? Reliance, NVIDIA To Build ChatGPT Rival Tailored For India

The companies together plan to create AI infrastructure that is more powerful than the fastest supercomputer in India, with NVIDIA offering access to its advanced NVIDIA GH200 Grace Hopper Superchip and NVIDIA DGX Cloud. 

Moreover, Reliance will create AI applications and services for its 450 million Jio customers and deliver energy-efficient AI infrastructure to scientists, developers and startups across India.

The companies expect to host AI infrastructure in AI-ready computing data centers, eventually expanding to 2,000 MW with execution and implementation to be managed by Jio.

“We are delighted to partner with Reliance to build state-of-the-art AI supercomputers in India. India has scale, data and talent. With the most advanced AI computing infrastructure, Reliance can build its own large language models that power generative AI applications made in India, for the people of India.” said Jensen Huang, founder and CEO of NVIDIA. 

Also ReadNvidia CEO Jensen Huang Sells $42 Million In Shares: What Investors Should Know

Price Action: NVDA shares are trading lower by 0.46% at $460.30 premarket on the last check Friday.

Total
0
Shares
Related Posts
Read More

Dr. Reddy’s Laboratories Ltd. And Bayer Entered Into A Partnership To Market And Distribute A Second Brand Of Vericiguat In India. Under The Terms Of This Agreement, Bayer Has Granted Non-Exclusive Rights To Dr. Reddy’s Under The Brand Name Gantra

- SEC Filing Dr. Reddy's Laboratories Ltd. ((BSE: 500124, NSE: DRREDDY, NYSE:RDY, NSEIFSC: DRREDDY, hereafter referred to as "Dr. Reddy's")) and Bayer announced that both companies have entered into a partnership to

RDY